Tenax Therapeutics
Price & Volume
Stats
See more52W Range | $3.61-$8.24 |
Market Cap | $34M |
Shares Short | 553,719 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $2.94 |
News
See moreYahoo Finance • 27 days ago
Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF
Yahoo Finance • 2 months ago
Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025
Yahoo Finance • 2 months ago
Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Yahoo Finance • 6 months ago
Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
About
CEO | Mr. Christopher T. Giordano |
CFO | Mr. Thomas A. McGauley |
Address | 101 Glen Lennox Drive, Chapel Hill, NC, United States, 27517 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 4 |
